Literature DB >> 8238259

Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse.

J Itoh1, M Nose, S Takahashi, M Ono, S Terasaki, E Kondoh, M Kyogoku.   

Abstract

MRL/Mp-lpr/lpr(MRL/lpr) lupus mice develop glomerulonephritis in which the histopathological manifestations of the disease are characterized by diffuse cell-proliferative, crescentic, and/or wire loop-like lesions, resembling those of human lupus nephritis. Although these lesions are thought to be mediated by antibodies, little data is available to explain these regular variations in glomerular lesions induced by antibodies at the monoclonal level. We studied glomerular lesions of normal or severe combined immunodeficient mice injected with nephritogenic immunoglobulin G3-producing hybridoma clones (2B11.3 and 7B6.8), which we previously established from an unmanipulated MRL/lpr mouse. Both clones caused increased serum levels of immunoglobulin G3 with identical patterns over time and both induced glomerular deposits of immunoglobulin G3 and C3. However, 2B11.3 and 7B6.8 induced glomerular lesions that differed in their histopathological manifestations. The 2B11.3 clone generated cell-proliferative lesions associated with marked Mac-2-positive macrophage infiltrates, but the 7B6.8 clone induced lesions characterized by subendothelial hyaline deposits resembling wire loops. The latter was not associated with significant inflammatory cell infiltrates at any point throughout the progression of the lesion. Thus, our findings suggest that the histopathological variation in glomerulonephritis seen in MRL/lpr mice results from clonally expanded B cell clones that produce nephritogenic antibodies with different pathogenic potencies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238259      PMCID: PMC1887158     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis.

Authors:  M Nose; M Nishimura; M Kyogoku
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

2.  Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy.

Authors:  I W McLean; P K Nakane
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

3.  Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates.

Authors:  F Ebling; B H Hahn
Journal:  Arthritis Rheum       Date:  1980-04

4.  Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo.

Authors:  M Nose; M Katoh; N Okada; M Kyogoku; H Okada
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

5.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

6.  Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies.

Authors:  M K Ho; T A Springer
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

7.  Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice.

Authors:  Y Gyotoku; M Abdelmoula; F Spertini; S Izui; P H Lambert
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

8.  Cloning and cDNA sequence analysis of nephritogenic monoclonal antibodies derived from an MRL/lpr lupus mouse.

Authors:  S Takahashi; J Itoh; M Nose; M Ono; T Yamamoto; M Kyogoku
Journal:  Mol Immunol       Date:  1993-02       Impact factor: 4.407

9.  Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus.

Authors:  S Izui; P J McConahey; A N Theofilopoulos; F J Dixon
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  10 in total

1.  A human anti-dsDNA monoclonal antibody caused hyaline thrombi formation in kidneys of 'leaky' SCID mice.

Authors:  L J Mason; C T Ravirajan; D S Latchman; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

2.  Experimental lupus nephritis in severe combined immunodeficient (SCID) mice: remodelling of the glomerular lesions by bystander IgM antibodies.

Authors:  M R Ito; S Terasaki; E Kondo; H Shiwaku; Y Fukuoka; M Nose
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  Arteritis in a novel congenic strain of mice derived from MRL/Lpr lupus mice: genetic dissociation from glomerulonephritis and limited autoantibody production.

Authors:  M Nose; M Nishimura; M R Ito; J Toh; T Shibata; T Sugisaki
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 4.  Mechanisms of genetic control of murine systemic lupus erythematosus.

Authors:  S Izui; R Merino; M Iwamoto; L Fossati
Journal:  Springer Semin Immunopathol       Date:  1994

Review 5.  Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies.

Authors:  Lucie Baudino; Samareh Azeredo da Silveira; Munehiro Nakata; Shozo Izui
Journal:  Springer Semin Immunopathol       Date:  2006-09-05

6.  Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis.

Authors:  J P Seery; J M Carroll; V Cattell; F M Watt
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

7.  Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.

Authors:  L Fossati-Jimack; A Ioan-Facsinay; L Reininger; Y Chicheportiche; N Watanabe; T Saito; F M Hofhuis; J E Gessner; C Schiller; R E Schmidt; T Honjo; J S Verbeek; S Izui
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

8.  Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity.

Authors:  Tomoko Ikeda; Hiroshi Fujii; Masato Nose; Yukiko Kamogawa; Tsuyoshi Shirai; Yuko Shirota; Tomonori Ishii; Hideo Harigae
Journal:  Arthritis Res Ther       Date:  2017-08-11       Impact factor: 5.156

9.  Possible role of complement factor H in podocytes in clearing glomerular subendothelial immune complex deposits.

Authors:  Takeshi Zoshima; Satoshi Hara; Masakazu Yamagishi; Ira Pastan; Taiji Matsusaka; Mitsuhiro Kawano; Michio Nagata
Journal:  Sci Rep       Date:  2019-05-27       Impact factor: 4.379

10.  Rapid and Complete Remission of Class IV Lupus Nephritis with Massive Wire Loop Lesions.

Authors:  Tomo Suzuki; Ryutaro Matsumura; Hiroshi Kitamura; Yugo Shibagaki
Journal:  Case Rep Nephrol Dial       Date:  2018-03-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.